ASND
Ascendis Pharma A/S
Price:  
157.60 
USD
Volume:  
502,233.00
Denmark | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

ASND Probability of Bankruptcy

The Probability of Bankruptcy of Ascendis Pharma A/S (ASND) is -% . This number represents the probability that ASND will face financial distress in the next 24 months given its current fundamentals and market conditions.

Multiple factors are taken into account when calculating ASND's probability of bankruptcy : Altman Z-score, Beneish M-score, financial position, macro environments, academic research about distress risk and more.

ASND - ESG ratings

ESG ratings are directly linked to the cost of capital and ASND's ability to raise funding, both of which can significantly affect the probability of Ascendis Pharma A/S going bankrupt.

ESG Score 56.75
Environment Score 34.98
Social Score 99.00
Governance Score 36.26
Returns
Historical Returns (5 day) 2.05%
Historical Returns (MTD) -7.53%
Historical Returns (YTD) 14.48%
Historical Returns (13 week) 10.60%
Historical Returns (26 week) 24.54%
Historical Returns (52 week) 27.06%
Efficiency
Asset Turnover 0.38
Receiveable Turnover 3.60
Gross Margin 87.83%
Operating Margin -76.66%
Pretax Margin -102.64%
Net Margin -103.97%
Return on Asset (ROA) -39.44
Return on Equity (ROE) -257.14
Return on Investments (ROI) -80.63
Price Metrics
Market Cap (M) 9,564.74
Enterprise Value (M)
52 Week High 183.00
52 Week Low 111.09
Beta 0.33
Average Volume (10 day) 0.52
Average Volume (3 month) 0.52
Price / Earnings (P/E)
Price / Sales (P/S) 26.16
Earnings
EPS -6.58
Revenue CAGR (5 year) 93.57%
Risk
Current Ratio 1.17
Quick Ratio 0.81